{
"NDC": {
"NDCCode": "33342-259-67",
"PackageDescription": "1 BOTTLE in 1 CARTON (33342-259-67) / 250 mL in 1 BOTTLE",
"NDC11Code": "33342-0259-67",
"ProductNDC": "33342-259",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Oxcarbazepine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Oxcarbazepine",
"DosageFormName": "FOR SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20250711",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA207300",
"LabelerName": "Macleods Pharmaceuticals Limited",
"SubstanceName": "OXCARBAZEPINE",
"StrengthNumber": "300",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-09-16",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250711",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}